- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT05983185
Prism Adaptation Therapy (PAT) pro rehabilitaci pravé mozkové příhody
Prism Adaptation Treatment (PAT) pro rehabilitaci pravé mozkové mrtvice
After a right brain stroke, >50% of Veterans experience problems with dressing, eating, self-care or steering their wheelchairs because their ability to move, orient, and respond toward the left side is limited: spatial neglect. Spatial neglect prevents them from functioning independently, and their needs in the hospital and at home are greatly increased. An effective treatment for spatial neglect is 10 days of visuomotor training while wearing optical prisms (PAT), however many clinicians [fail to diagnose spatial neglect and use this approach. In this study, the investigators will develop a brain scanning test that could objectively identify the Veterans with spatial neglect after stroke who are the best candidates to receive PAT and recover their ability to function. When the research is complete, the investigators expect that brain scans done in the hospital can guide the team to refer Veterans to PAT rehabilitation: improving daily life function] and quality of life.
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Project Summary/Abstract The application addresses the formidable treatment gap for cognitive rehabilitation of spatial neglect (SN), defined as asymmetric orienting, perception, and responding to left space after right brain stroke, causing functional disability. Although Veterans with SN are half as likely to return home, have one-third the community mobility, require 3x as much caregiver supervision, and have longer hospitalizations, increased fall risk and increased rehospitalization compared with similar right brain stroke survivors, a personalized approach to SN rehabilitation is not available in Veteran-specific systems of care. The investigators discovered that frontal lobe damage and "Aiming" SN both predict optimal recovery of functional independence after prism adaptation treatment (PAT). These findings argue for the development of an [objective, biomarker-based process to identify patients who should be administered PAT. The algorithm will be developed by identifying specific neurobiological features predictive of PAT treatment response. Thus, the investigators expect this research will deliver a critical missing element to rehabilitation, eliminating clinician uncertainty about SN diagnosis and appropriateness of PAT, and allowing a more personalized health care approach to SN rehabilitation. The team of researchers at three high-performing VA medical centers, distinguished in cognitive neurology analysis of brain imaging predictors, and stroke rehabilitation, from both advanced and clinical data, will develop the first biological parameter that can be used to assign SN rehabilitation. In 180 Veterans (120 with SN, 60 without), the investigators will define and validate brain imaging biomarkers that predict the presence of Aiming SN (Aim 1), a strong predictor of functional recovery after receiving PAT. The expectation that disconnection of frontal regions with subcortical and parietal regions will predict Aiming SN. The investigators will also examine the correlation between the brain imaging biomarkers predicting Aiming SN and improvements in daily life function after PAT (Aim 2).] Then, the investigators will determine if adding behavioral predictors to biomarker predictors (Aim 3) accounts for additional variance in the trajectory of functional recovery. The overall impact of the investigators' work will be to establish the utility of a validated biomarker that routinely identifies Veterans with SN after stroke who are the best candidates for PAT. Armed with a biomarker-based algorithm, the investigators can then carry out a large-scale PAT clinical trial, and personalized SN care. This care pathway could reduce reliance on specialized SN assessment, [coordinate VA and community systems providing Veteran stroke care,] and improve stroke care efficiency, to enhance outcomes and quality of life after stroke for thousands of Veterans.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Anna M Barrett, MD
- E-mail: Anna.Barrett2@va.gov
Studijní záloha kontaktů
- Jméno: Akila Sanjay, BA
- Telefonní číslo: (508) 856-0104
- E-mail: akila.sanjay@va.gov
Studijní místa
-
-
Connecticut
-
West Haven, Connecticut, Spojené státy, 06516-2770
- Nábor
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Kontakt:
- Sharon Bottomley, DNP
- Telefonní číslo: 203-932-5711
- E-mail: sharon.bottomley@va.gov
-
Kontakt:
- Nishant Mishra, MD
- Telefonní číslo: 6504408349
- E-mail: nishant.mishra@va.gov
-
-
Georgia
-
Decatur, Georgia, Spojené státy, 30033-4004
- Nábor
- Atlanta VA Medical and Rehab Center, Decatur, GA
-
Kontakt:
- Michael Dattilo, MD
- Telefonní číslo: 20660 4043216111
- E-mail: michael.datillo@va.gov
-
Kontakt:
- Mychaela Eatmon
- Telefonní číslo: 404-725-3256
- E-mail: mychaela.eatmon@va.gov
-
-
Massachusetts
-
Leeds, Massachusetts, Spojené státy, 01053-9764
- Nábor
- VA Central Western Massachusetts Healthcare System, Leeds, MA
-
Vrchní vyšetřovatel:
- Anna M. Barrett, MD
-
Kontakt:
- Anna M Barrett, MD
- E-mail: Anna.Barrett2@va.gov
-
Kontakt:
- Emily Muller, BA
- Telefonní číslo: 508-254-7217
- E-mail: emily.muller@umassmed.edu
-
-
Ohio
-
Cleveland, Ohio, Spojené státy, 44106-1702
- Nábor
- Louis Stokes VA Medical Center, Cleveland, OH
-
Kontakt:
- Jessica McCabe, PT
- Telefonní číslo: 8203830 216-791-3800
- E-mail: jessica.mccabe@va.gov
-
Kontakt:
- Svetlana Pundik
- Telefonní číslo: 63732 2167913800
- E-mail: svetlana.pundik@va.gov
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Has had a first right brain stroke >18 years of age
- 1-4 months post-diagnosis of right brain stroke
- Can sit up, see out of both eyes and point to objects (>20/50 vision in both eyes)
- Can give informed consent to participate
Exclusion Criteria:
- Has been diagnosed with other chronic, disabling neurological disorder (e.g. multiple sclerosis, Alzheimer Disease)
- Has had a clinical left brain stroke or has neuroimaging evidence of prior stroke(s) including the presence of more than two lacunes with diameter greater than 15 mm.
- Cannot sit up to be tested and receive PAT
- Has <20/50 vision when viewing with both eyes
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Diagnostický
- Přidělení: Nerandomizované
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Prism adaptation Therapy
People with spatial neglect will receive this effective treatment to reduce symptoms, which the investigators' previous work indicated may be particularly effective for Aiming SN symptoms. |
The investigators' research and clinical group is the US leader in implementing this intervention for spatial neglect and have brought it to more than 50 clinical centers, hospitals, and treatment organizations.
Ostatní jména:
|
|
Žádný zásah: No spatial neglect
People without spatial neglect symptoms will not receive an intervention for spatial neglect. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Spatial neglect (SN) type (Aiming SN versus Where SN)
Časové okno: baseline
|
This variable is assignment to category defining spatial neglect. This is based on a data collection with computerized line bisection, which generates a profile score. Veterans whose computerized line bisection profile score indicates that they have spatial neglect that primarily affects movement, intention and action have Aiming SN; these Veterans responded best to prism adaptation therapy (PAT) in prior research. Alternately, Veterans may have a profile score consistent with Where SN, affecting perception and action. |
baseline
|
|
Functional independence Measure (FIM) improvement trajectory
Časové okno: 5 weeks after enrollment
|
This outcome variable measures how well Veterans can carry out their daily life self-care activities independently on a validated measure, the Functional Independence Measure (FIM). |
5 weeks after enrollment
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
SN severity, as assessed by the Behavioral Inattention Test-conventional subtest (BIT-c)
Časové okno: 5 weeks after enrollment
|
This variable examines the severity of spatial neglect as measured by functionally-valid assessment, the Behavioral Inattention Test-conventional subtest (BIT-c; max value 146, min value 0, lower is abnormal). Functionally-valid spatial neglect assessments predict independence for activities of daily living, and care needs. |
5 weeks after enrollment
|
|
SN severity, as assessed by the Catherine Bergego Scale (CBS)
Časové okno: 5 weeks after enrollment
|
This variable (max value 30, min value 0, higher is abnormal) examines the severity of spatial neglect as measured by a functionally-valid assessment, the CBS. Functionally-valid spatial neglect assessments predict independence for activities of daily living, and care needs. |
5 weeks after enrollment
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Anna M. Barrett, MD, VA Central Western Massachusetts Healthcare System, Leeds, MA
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- C3662-R
- 1I01RX003662-01A1 (Grant/smlouva NIH USA)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .